Tech Company Financing Transactions
Xagenic Funding Round
On 7/10/2015, Xagenic raised $11.8 million in Series B financing from BDC Venture Capital, CTI Life Sciences Fund and Domain Associates.
Transaction Overview
Company Name
Announced On
7/10/2015
Transaction Type
Venture Equity
Amount
$11,780,000
Round
Series B
Investors
Proceeds Purpose
This funding will accelerate our development efforts in bringing our point-of-care diagnostic platform to market.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 York St. 1000
Toronto ON, M5J 1R7
Canada
Toronto ON, M5J 1R7
Canada
Phone
Website
Email Address
Overview
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shana Kelley
Chief Financial Officer
Edward Jonasson
Chief Operating Officer
Randall Wilhoite
VP - R & D
Graham Jack
Browse more venture capital transactions:
Prev: 7/10/2015: Intuity Medical venture capital transaction
Next: 7/10/2015: TicTasks venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs